Visible and Sub-visible Particle Formation for a Model Bioconjugate

被引:0
|
作者
Lavinia M. Lewis
Michelle E. Pizzo
Sandipan Sinha
Syed S. Ahmed
Liji Joseph
机构
[1] Biotherapeutics Pharmaceutical Sciences,Division of Pharmaceutical Sciences
[2] Pfizer,undefined
[3] School of Pharmacy,undefined
[4] Gilead,undefined
来源
AAPS PharmSciTech | 2017年 / 18卷
关键词
bioconjugate; interfacial area; kinetics; sub-visible particles; visible particles;
D O I
暂无
中图分类号
学科分类号
摘要
The time-course and extent of visible particle (VP) and sub-visible particle (SVP) formation was monitored as a function of interfacial area (IA) for a model bioconjugate. To facilitate particle formation, the bioconjugate was agitated in a glass vial and exposed to IAs up to 478 mm2. Since vials had equal fill and headspace volumes, the area of the air-water interface was varied by placing vials on angled blocks at 0°, 30°, 60°, or 90° from the horizontal. A significant increase in visible and sub-visible particle formation was observed with increasing air-water IA. Exposure to IAs below ∼305 mm2 resulted in the formation of very few particles, while IAs > ∼305 mm2 resulted in substantial particle formation. Visible and sub-visible particle morphology varied with interfacial area and time. The sub-visible particles initially increased with time but did not reach steady state; instead the initial increase was followed by complete depletion. These phenomena indicate that visible particle formation likely increased at the expense of the sub-visible particle population and demonstrate a potential link between the two particle populations for this model bioconjugate. Initiation of particle formation did not result in corresponding decreases in protein concentration or increases in soluble aggregates. However, extended agitation time resulted in a significant decrease in protein concentration.
引用
收藏
页码:926 / 931
页数:5
相关论文
共 50 条
  • [1] Visible and Sub-visible Particle Formation for a Model Bioconjugate
    Lewis, Lavinia M.
    Pizzo, Michelle E.
    Sinha, Sandipan
    Ahmed, Syed S.
    Joseph, Liji
    AAPS PHARMSCITECH, 2017, 18 (03): : 926 - 931
  • [2] Screening techniques for monitoring the sub-visible particle formation of free fatty acids in biopharmaceuticals
    Chen, Wei
    Klemm, Denis
    Gregoritza, Kathrin
    Kishore, Ravuri Satya Krishna
    Stracke, Jan Olaf
    Wurth, Christine
    Pinto, Cosimo
    Oltra, Nuria Sancho
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 190 : 242 - 247
  • [3] The microscope: mediations of the sub-visible world
    Armstrong, I
    TRANSACTIONS AND ENCOUNTERS: SCIENCE AND CULTURE IN THE NINETEENTH CENTURY, 2002, : 30 - 54
  • [4] Analysis of sub-visible particles
    Maier, Marcia
    Zerulla-Wernitz, Melanie
    Pharmaceutical Technology, 2019, 2019 (01)
  • [5] Characterization of sub-visible and visible monoclonal antibody aggregates
    Wayment, Joshua R.
    Guha, Suvajyoti
    Tarlov, Michael J.
    Zachariah, Michael
    Ripple, Dean C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [6] Evaluation of particle size distribution of sub-visible particles in powder injections with different packaging forms - small-sized sub-visible particles should not be ignored
    Wang, Tao
    Lu, Enhao
    Dai, Qiwen
    Huang, Xueli
    Yao, Qiquan
    Sha, Xianyi
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023, 49 (09) : 551 - 558
  • [7] Enhancement of viral filtration performance by characterization of the foulant particulates and controlling factors contributing to sub-visible particle formation
    Woo, James
    Emery, Rachel
    Garcia, Carlos
    Sanaie, Nooshafarin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [8] Formation of protein sub-visible particles during powder grinding of a monoclonal antibody
    Qian, Ci
    Wang, Guanqi
    Wang, Xinyu
    Barnard, James
    Gao, Jian-Qing
    Bao, Wenhan
    Wang, Haibin
    Li, Fengzhu
    Ingle, Rahul Gajanan
    Fang, Wei-Jie
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 149 : 1 - 11
  • [9] Formation of protein sub-visible particles during vacuum degassing of etanercept solutions
    Wang, Haibin
    Zheng, Hong-Jian
    Wang, Zhao
    Bai, Hua
    Carpenter, John F.
    Chen, Shuqing
    Fang, Wei-Jie
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 66 : 151 - 157
  • [10] Protein Sub-Visible Particle and Free Radical formation of a Freeze-Dried Monoclonal Antibody Formulation During Dropping
    Fang, Wei-Jie
    Liu, Jia-Wei
    Zheng, Hong-Jian
    Shen, Bin-Bin
    Wang, Xinyu
    Kong, Yi
    Jing, Zhen-Yi
    Gao, Jian-Qing
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (04) : 1625 - 1634